- Trials with a EudraCT protocol (153)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
153 result(s) found for: Cardiovascular Magnetic Resonance Imaging.
Displaying page 1 of 8.
EudraCT Number: 2014-002455-26 | Sponsor Protocol Number: IRON-CMR | Start Date*: 2014-09-20 |
Sponsor Name:Karolinska Institute | ||
Full Title: The use of intravenous Iron oxide as a contrast agent for cardiac magnetic resonance imaging. | ||
Medical condition: Cardiovascular diseases: Acute myocardial infarction, chronic myocardial infarction, myocardial ischemia, myocarditis, diffuse myocardial fibrosis. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004346-10 | Sponsor Protocol Number: N/A | Start Date*: 2015-04-15 |
Sponsor Name:Alder Hey Children's NHS Foundation Trust | ||
Full Title: Study to evaluate the optimal dose of remifentanil infusion(effective dose in 80% of patients) required to ensure apnoea (of 30 seconds duration) during magnetic resonance imaging of the heart unde... | ||
Medical condition: Study refers to the use of this medicine during anaesthesia given during the investigation of congenital heart disease. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003234-32 | Sponsor Protocol Number: UKM13_0018 | Start Date*: 2014-12-02 |
Sponsor Name:Universitätsklinikum Münster | ||
Full Title: Pathological changes in the myocardial microvasculature - a MR-based quantification | ||
Medical condition: Patients with cardiovascular diseases and suspect of myocardial microvasculopathy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005784-24 | Sponsor Protocol Number: MEIXO-VALV-001 | Start Date*: 2012-06-14 |
Sponsor Name:Andres Iñiguez Romo | ||
Full Title: Dual antiplatelet therapy versus oral anticoagulation for a short time to prevent cerebral embolism after percutaneous aortic valve implantation. Multicenter randomized clinical trial. | ||
Medical condition: Evaluate the efficacy of dual antiplatelet therapy versus oral anticoagulation for primary prevention of cerebral thromboembolism at three months after percutaneous aortic valve implantation (TAVI). | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-001682-12 | Sponsor Protocol Number: MYOFLAME-19 | Start Date*: 2023-06-16 | ||||||||||||||||
Sponsor Name:Goethe University Frankfurt | ||||||||||||||||||
Full Title: Randomised placebo controlled clinical trial of efficacy of MYOcardial protection in patients with postacute inFLAMmatory cardiac involvEment due to COVID-19 (MYOFLAME-19) | ||||||||||||||||||
Medical condition: Inflammatory cardiovascular involvement due to COVID-19, defined by Cardiovascular magnetic resonance imaging | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002940-28 | Sponsor Protocol Number: ISRCTN46528154 | Start Date*: 2006-10-09 |
Sponsor Name:ICIN [...] | ||
Full Title: HEBE III: A prospective, randomised, double blind, placebo controlled clinical study to examine the effects of a single bolus erythropoietin on left ventricular function in patients with an acute m... | ||
Medical condition: Patients with a successful primary PCI (TIMI 2/3) for a first acute myocardial infarction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001069-18 | Sponsor Protocol Number: 12/0533 | Start Date*: 2013-07-11 | |||||||||||
Sponsor Name:University College London (UCL) | |||||||||||||
Full Title: MINeralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-Elevation Myocardial Infarction(STEMI). | |||||||||||||
Medical condition: Cardiovascular disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003218-36 | Sponsor Protocol Number: 82646 | Start Date*: 2023-06-05 |
Sponsor Name:Radboudumc | ||
Full Title: The safety of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction and the effect on intramyocardial haemorrhage | ||
Medical condition: Acute myocardial infarction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-008936-10 | Sponsor Protocol Number: NIMINI-1/2 | Start Date*: 2009-03-16 | |||||||||||
Sponsor Name:Division of Cardiology, Robert-Bosch-Krankenhaus | |||||||||||||
Full Title: Comparative evaluation of different CMR pulse-sequences with respect to their practicability and diagnostic performance in diagnosing the inflamed myocardium in patients with acute myocardial infar... | |||||||||||||
Medical condition: Patients with acute myocardial infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005109-19 | Sponsor Protocol Number: ATTICUS | Start Date*: 2015-11-10 |
Sponsor Name:University Hospital Tuebingen | ||
Full Title: Apixaban for treatment of embolic stroke of undetermined source | ||
Medical condition: Patients with embolic stroke of undetermined source and at least on risk factor for cardiac embolism | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-001408-37 | Sponsor Protocol Number: CARDIODIAB | Start Date*: 2011-06-08 | |||||||||||
Sponsor Name:FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR | |||||||||||||
Full Title: Effects of Liraglutide on left ventricular (LV) morphology, function and energy metabolism in patients with type 2 diabetes and heart failure : an in vivo cardiac Magnetic Resonance Imaging and 31P... | |||||||||||||
Medical condition: patients affected by type 2 diabetes and heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001876-32 | Sponsor Protocol Number: SLN360-002 | Start Date*: 2023-04-14 | ||||||||||||||||
Sponsor Name:Silence Therapeutics plc | ||||||||||||||||||
Full Title: A multi-centre, randomised, double-blind placebo-controlled, Phase 2 study to investigate efficacy, safety and tolerability of SLN360 in participants with elevated lipoprotein(a) at high risk of at... | ||||||||||||||||||
Medical condition: elevated lipoprotein (a) and high risk of atherosclerotic cardiovascular disease (ASCVD) events | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) NL (Ongoing) SK (Ongoing) DK (Ongoing) CZ (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005212-40 | Sponsor Protocol Number: MR080508 | Start Date*: 2008-10-14 | ||||||||||||||||||||||||||
Sponsor Name:Karolinska Institute | ||||||||||||||||||||||||||||
Full Title: Pain mechanisms and fatigue in rheumatoid arthritis (RA) and healthy volunteers. Can antirheumatic and biological therapy affect pain processing and fatigue in RA? | ||||||||||||||||||||||||||||
Medical condition: Rheumatoid arthritis (RA) The overall aim with this project is to investigate central pain mechanisms in RA and healthy controls, and in RA how these are influenced by autonomic neural regulation ... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: SE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000456-17 | Sponsor Protocol Number: 43466 | Start Date*: 2019-10-16 | |||||||||||
Sponsor Name:University Hospital Maastricht | |||||||||||||
Full Title: Plaque at risk (ParisK): Molecular imaging of plaque vulnerability using 18F-choline PET-CT and MRI in carotid artery atherosclerosis patients | |||||||||||||
Medical condition: Patients with carotid artery stenosis due to atherosclerosis, who are scheduled for carotid endarterectomy or are treated conservatively. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010170-38 | Sponsor Protocol Number: CSPP100G2301 | Start Date*: 2010-07-21 | ||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | ||||||||||||||||||
Full Title: A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People Aliskiren Prevention Of Later Life Outcomes (APOLLO) | ||||||||||||||||||
Medical condition: cardiovacular disease, fonctional hypertension, | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Prematurely Ended) HU (Completed) DE (Completed) IE (Prematurely Ended) CZ (Prematurely Ended) ES (Prematurely Ended) NL (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-001802-30 | Sponsor Protocol Number: TMP-3001-2020-30 | Start Date*: 2021-10-28 |
Sponsor Name:Fraunhofer Institut für Translationale Medizin und Pharmakologie (ITMP) | ||
Full Title: Efficacy of belimumab to improve subclinical cardiovascular abnormalities using imaging endpoints with cardiac magnetic resonance in patients with systemic lupus erythematosus (BeCarma) | ||
Medical condition: Efficacy of belimumab to improve subclinical cardiovascular abnormalities using imaging endpoints with cardiac magnetic resonance in patients with systemic lupus erythematosus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002514-23 | Sponsor Protocol Number: Car20130917 | Start Date*: 2015-01-07 |
Sponsor Name:VU Medical Center | ||
Full Title: Reduction Of Microvascular Injury Utilizing Sonolysis | ||
Medical condition: Myocardial infarction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-006639-24 | Sponsor Protocol Number: 2020/ABM/01/00080 | Start Date*: 2022-10-19 |
Sponsor Name:The Cardinal Stefan Wyszyński Institute of Cardiology | ||
Full Title: Multicenter Polish Study of the Use of Bromocriptine in Perinatal Cardiomyopathy. New BioMarkers in the Early Diagnosis of Peripartum CardioMyopathy. PolBrom-PPCM | ||
Medical condition: PeriPartum Cardiomiopathy | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: PL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003141-42 | Sponsor Protocol Number: EX9924-4473 | Start Date*: 2019-07-03 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes | |||||||||||||
Medical condition: Diabetes Mellitus, Type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) NL (Ongoing) GB (GB - no longer in EU/EEA) SK (Ongoing) DE (Ongoing) BE (Ongoing) AT (Ongoing) ES (Ongoing) CZ (Ongoing) HR (Ongoing) IT (Ongoing) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002496-10 | Sponsor Protocol Number: GS-US-402-1852 | Start Date*: 2017-02-21 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Nonalcoholic Steatohepatitis (NASH) | |||||||||||||
Medical condition: Nonalcoholic steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.